Genetic Analysis AS (XSAT:GEAN)
0.6700
-0.0400 (-5.63%)
At close: Aug 25, 2026
Genetic Analysis AS Revenue
Genetic Analysis AS had revenue of 4.39M NOK in the quarter ending March 31, 2026, with 9.36% growth. This brings the company's revenue in the last twelve months to 36.19M, up 81.59% year-over-year. In the year 2025, Genetic Analysis AS had annual revenue of 21.17M with 2.36% growth.
Revenue (ttm)
36.19M NOK
Revenue Growth
+81.59%
P/S Ratio
2.24
Revenue / Employee
2.01M NOK
Employees
18
Market Cap
47.06M SEK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.17M | 488.00K | 2.36% |
| Dec 31, 2024 | 20.68M | -2.48M | -10.71% |
| Dec 31, 2023 | 23.16M | 2.42M | 11.65% |
| Dec 31, 2022 | 20.75M | 7.37M | 55.08% |
| Dec 31, 2021 | 13.38M | 5.62M | 72.54% |
| Dec 31, 2020 | 7.75M | -10.08M | -56.52% |
| Dec 31, 2019 | 17.83M | 12.41M | 229.04% |
| Dec 31, 2018 | 5.42M | 2.49M | 84.76% |
| Dec 31, 2017 | 2.93M | 2.13M | 265.78% |
| Dec 31, 2016 | 801.95K | -1.45M | -64.32% |
| Dec 31, 2015 | 2.25M | 1.40M | 163.58% |
| Dec 31, 2014 | 852.82K | 198.00K | 30.24% |
| Dec 31, 2013 | 654.82K | -1.20M | -64.78% |
| Dec 31, 2012 | 1.86M | -996.89K | -34.90% |
| Dec 31, 2011 | 2.86M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mendole | 197.80M |
| Beyond Frames Entertainment AB | 139.93M |
| Lightning Group AB | 76.46M |
| Gomero Group AB | 51.99M |
| QBNK Holding AB | 40.26M |
| Redsense Medical AB | 26.46M |
| Kontigo Care AB | 25.69M |
| Touchtech AB | 20.16M |
Genetic Analysis AS News
- 3 months ago - Genetic Analysis AS Quarterly report: Q1 2026 - Filings
- 6 months ago - Genetic Analysis AS Quarterly report: Q4 2025 - Filings
- 6 months ago - Genetic Analysis AS Annual report: Q4 2025 - Filings
- 9 months ago - Genetic Analysis AS Quarterly report: Q3 2025 - Filings
- 1 year ago - Genetic Analysis AS Quarterly report: Q2 2025 - Filings